Molecular and biological characterization of a replication competent human immunodeficiency type 2 (HIV-2) proviral clone

scientific article

Molecular and biological characterization of a replication competent human immunodeficiency type 2 (HIV-2) proviral clone is …
instance of (P31):
scholarly articleQ13442814

External links are
P819ADS bibcode1989PNAS...86.2433F
P356DOI10.1073/PNAS.86.7.2433
P932PMC publication ID286927
P698PubMed publication ID2648404
P5875ResearchGate publication ID20508625

P50authorRobert GalloQ469904
Eva Maria FenyöQ89369110
Jan AlbertQ39183357
P2093author name stringFranchini G
Biberfeld G
De Rossi A
Jagodzinski L
Bosch M
Fargnoli KA
Giombini F
P2860cites workThe human immunodeficiency virus type 2 (HIV-2) contains a novel gene encoding a 16 kD protein associated with mature virionsQ42653163
The simian immunodeficiency virus envelope open reading frame located after the termination codon is expressed in vivo in infected animalsQ42654446
Isolation and characterization of a novel protein (X-ORF product) from SIV and HIV-2.Q42658314
Ultrastructural characterization of a new human B lymphotropic DNA virus (human herpesvirus 6) isolated from patients with lymphoproliferative disease.Q43967221
Genetic analysis of a new subgroup of human and simian T-lymphotropic retroviruses: HTLV-IV, LAV-2, SBL-6669, and STLV-IIIAGM.Q44238578
The AIDS virusQ44559514
The sor gene of HIV-1 is required for efficient virus transmission in vitroQ45831189
Sequence of simian immunodeficiency virus and its relationship to the human immunodeficiency virusesQ45831194
Human immunodeficiency virus: the eighth geneQ45831425
Type-Restricted Neutralization of Molecular Clones of Human Immunodeficiency VirusQ45832058
Sequence of simian immunodeficiency virus from African green monkey, a new member of the HIV/SIV groupQ45832109
Trans-activator gene of human T-lymphotropic virus type III (HTLV-III).Q45838520
The HIV 'A' (sor) gene product is essential for virus infectivityQ45847960
Genetic variability of the AIDS virus: nucleotide sequence analysis of two isolates from African patientsQ45848343
Human and simian immunodeficiency retroviruses: activation and differential transactivation of gene expressionQ46412923
Transmission of HTLV-III Infection from Human Plasma to Chimpanzees: An Animal Model for AIDSQ52849903
A new human retrovirus isolate of West African origin (SBL-6669) and its relationship to HTLV-IV, LAV-II, and HTLV-IIIB.Q53883523
DNA sequencing with chain-terminating inhibitorsQ22066207
Isolation of a T-Lymphotropic Retrovirus from a Patient at Risk for Acquired Immune Deficiency Syndrome (AIDS)Q22242256
Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applicationsQ24561689
DNA sequence analysis with a modified bacteriophage T7 DNA polymeraseQ24605322
A new method for sequencing DNAQ24605576
Detection of specific sequences among DNA fragments separated by gel electrophoresisQ25939003
Frequent Detection and Isolation of Cytopathic Retroviruses (HTLV-III) from Patients with AIDS and at Risk for AIDSQ29614260
Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphomaQ29615115
Genetic variability between isolates of human immunodeficiency virus (HIV) type 2 is comparable to the variability among HIV type 1.Q33639547
Isolation of a lentivirus from a macaque with lymphoma: comparison with HTLV-III/LAV and other lentiviruses.Q33927613
Isolation of a new human retrovirus from West African patients with AIDS.Q34038984
Genome organization and transactivation of the human immunodeficiency virus type 2.Q34048704
Isolation of T-cell tropic HTLV-III-like retrovirus from macaquesQ34049156
Pneumocystis carinii pneumonia and mucosal candidiasis in previously healthy homosexual men: evidence of a new acquired cellular immunodeficiencyQ34055177
Antibodies Reactive with Human T-Lymphotropic Retroviruses (HTLV-III) in the Serum of Patients with AIDSQ34055350
A second post-transcriptional trans-activator gene required for HTLV-III replicationQ34162178
Isolation of an HTLV-III-related retrovirus from macaques with simian AIDS and its possible origin in asymptomatic mangabeysQ34162184
Identification of a protein encoded by the vpu gene of HIV-1.Q34163678
HTLV-III expression and production involve complex regulation at the levels of splicing and translation of viral RNA.Q34186306
Molecular analysis of a deletion mutant provirus of type I human T-cell lymphotropic virus: evidence for a doubly spliced x-lor mRNA.Q35583581
Isolation of a T-lymphotropic retrovirus from naturally infected sooty mangabey monkeys (Cercocebus atys).Q35617653
The effect of helper virus on Abelson virus-induced transformation of lymphoid cellsQ36340152
Sequence of simian immunodeficiency virus from macaque and its relationship to other human and simian retrovirusesQ36470925
Expression of the art/trs protein of HIV and study of its role in viral envelope synthesisQ41886681
P433issue7
P407language of work or nameEnglishQ1860
P1104number of pages5
P304page(s)2433-2437
P577publication date1989-04-01
P1433published inProceedings of the National Academy of Sciences of the United States of AmericaQ1146531
P1476titleMolecular and biological characterization of a replication competent human immunodeficiency type 2 (HIV-2) proviral clone
P478volume86

Reverse relations

cites work (P2860)
Q37517645A genotypic method for determining HIV-2 coreceptor usage enables epidemiological studies and clinical decision support
Q46444674A highly divergent HIV-2-related isolate
Q37844065Animal models for development of an AIDS vaccine
Q36784415Biological and molecular variability of human immunodeficiency virus type 2 isolates from The Gambia
Q34323939CD4-Pseudomonas exotoxin hybrid protein blocks the spread of human immunodeficiency virus infection in vitro and is active against cells expressing the envelope glycoproteins from diverse primate immunodeficiency retroviruses
Q45859740Comparison of Linear Antigenic Sites in the Envelope Proteins of Human Immunodeficiency Virus (HIV) Type 2 and Type 1
Q40024144Comparison of anti-viral activity of rhesus monkey and cynomolgus monkey TRIM5alphas against human immunodeficiency virus type 2 infection
Q36698091Cross-neutralization of human immunodeficiency virus type 1 and 2 and simian immunodeficiency virus isolates
Q36797933Cytopathic variants of an attenuated isolate of human immunodeficiency virus type 2 exhibit increased affinity for CD4.
Q36701891Dispensable role of the human immunodeficiency virus type 2 Vpx protein in viral replication
Q36641861Distinguishing features of an infectious molecular clone of the highly divergent and noncytopathic human immunodeficiency virus type 2 UC1 strain
Q24540298Envelope glycoprotein cytoplasmic domains from diverse lentiviruses interact with the prenylated Rab acceptor
Q33938392Evolution of the primate lentiviruses: evidence from vpx and vpr
Q33604826Evolutionary origin of human and simian immunodeficiency viruses
Q40760950Fine characterization of a V3-region neutralizing epitope in human immunodeficiency virus type 2.
Q36637244Genetic diversity of human immunodeficiency virus type 2: evidence for distinct sequence subtypes with differences in virus biology
Q33814659Human immunodeficiency virus type 2 produces a defect in CD3-gamma gene transcripts similar to that observed for human immunodeficiency virus type 1.
Q36811248Human immunodeficiency virus types 1 and 2 and simian immunodeficiency virus env proteins possess a functionally conserved assembly domain
Q39242650Human infection by genetically diverse SIVSM-related HIV-2 in west Africa
Q37546827Hyperimmune antisera against synthetic peptides representing the glycoprotein of human immunodeficiency virus type 2 can mediate neutralization and antibody-dependent cytotoxic activity
Q36803768Identification of a cis-acting element in human immunodeficiency virus type 2 (HIV-2) that is responsive to the HIV-1 rev and human T-cell leukemia virus types I and II rex proteins
Q36699146In vivo genetic variability of the human immunodeficiency virus type 2 V3 region
Q35861329Inhibitory activity of the equine infectious anemia virus major 5' splice site in the absence of Rev
Q41687797Interaction of C-terminal sequences of human immunodeficiency virus reverse transcriptase with template primer
Q36797905Localization of immunogenic domains in the human immunodeficiency virus type 2 envelope
Q39875204Location, exposure, and conservation of neutralizing and nonneutralizing epitopes on human immunodeficiency virus type 2 SU glycoprotein
Q36287468Mapping the determinants of human immunodeficiency virus 2 for infectivity, replication efficiency, and cytopathicity
Q36801331Molecular characterization of an attenuated human immunodeficiency virus type 2 isolate
Q43897670Neutralizing Monoclonal Antibody against an External Envelope Glycoprotein (gp110) of SIVmac251
Q35839457Neutralizing monoclonal antibodies against human immunodeficiency virus type 2 gp120
Q36783146Persistent infection of rhesus macaques with a molecular clone of human immunodeficiency virus type 2: evidence of minimal genetic drift and low pathogenetic effects
Q36699125Role of the fusogenic peptide sequence in syncytium induction and infectivity of human immunodeficiency virus type 2.
Q44079254Specificity of new peptide immunoassays versus other immunoassays and agglutination tests for detection of HIV antibody in African Sera
Q36684349Strain-specific neutralizing determinant in the transmembrane protein of simian immunodeficiency virus
Q33849520The human immunodeficiency virus type 2 vpr gene is essential for productive infection of human macrophages
Q33935811The nef gene of simian immunodeficiency virus SIVmac1A11
Q36685908Transdominant inhibition of wild-type human immunodeficiency virus type 2 replication by an envelope deletion mutant.
Q36632917Variability of the env gene in cynomolgus macaques persistently infected with human immunodeficiency virus type 2 strain ben.

Search more.